Questions people ask me

Why have you worked in so many industries?

Because I follow one skill, reading people and systems, into wherever it can move a number that matters.

I started in customer service at Grameenphone, about 80,000 conversations, to learn how people actually decide. Then brand at MGH Group in logistics, and brand and digital at two of Bangladesh’s biggest advertising agencies, Grey Dhaka and Asiatic JWT, where much of the work was for FMCG brands such as Unilever’s Lux. Then fintech at SureCash, where a government stipend reached 10 million beneficiaries. E-commerce at Ekhanei, where a category reached No. 1 in two and a half months. Consumer tech at Samsung, where I ran the mobile line for Bangladesh the way an FMCG brand manager runs a brand, and the Galaxy Note9 launch ranked first globally for growth. Education at ACCA. During the pandemic I pointed all of it at healthcare, where growth also improves lives.

Eight industries in seventeen years, one job: find the number that matters, read the people and the system around it, and move it.

EvidenceThe Impact map: all 21 resultsEssay: the dual-market operator’s edge

Can you lead growth outside healthcare?

Yes, and the record runs the other way from what people assume. My growth and outcome results came first, and most of them came outside healthcare: a No. 1 category in e-commerce in two and a half months, Samsung’s Note9 ranked first globally for growth, a fintech that reached 10 million beneficiaries, brand and digital work at two of Bangladesh’s biggest advertising agencies, Grey Dhaka and Asiatic JWT, and ACCA in education. Twelve years of that, across seven industries, before I touched public health.

The MPH and CHES came later, during the pandemic, because I wanted to point those same skills at the market where growth is hardest: regulated, evidence-bound, and built on trust. Health education is behaviour change at scale, which is what marketing is when it is done honestly. If a method works there, it works in SaaS, retail or finance with fewer constraints.

So read the MPH as an addition, not a pivot. What I bring to any industry is the same: find the number that matters, read the people and the system around it, and move it. The Impact map holds all 21 results. About half of them are outside healthcare, and you can filter by organisation to see each one on its own.

EvidenceSamsung Galaxy Note9 caseSureCash: 10 million beneficiariesThe Impact map

What growth results have you delivered outside health?

Pick an industry and there is a number. Consumer tech: Samsung’s Galaxy Note9 launch, 1.54 times year on year and ranked first globally for growth, and the J2 line at about 2,600 units a day. E-commerce: Ekhanei’s vehicle category to No. 1 in two and a half months, and Bike Bazaar, an offline trade built on trust. Fintech: a government stipend delivered to 10 million beneficiaries through SureCash. Advertising: Asiatic Digital built from the ground up, and the Lux Channel i Superstar platform. Education: ACCA’s member ecosystem, 100 percent of 2020 to 2021 targets with 98.2 percent retention.

Then the same method took Praava Health through multi-year hypergrowth. Different industries, one method.

EvidenceNote9Ekhanei category launchAsiatic DigitalACCA ecosystem

What is your proof in health, for business growth and population outcomes?

Both, and they connect. On the business side: at Praava Health I directed growth through a multi-year hypergrowth run, around 45 percent overall and 57 percent business-to-consumer compound annual growth from 2021 to 2023, built a corporate sales engine from zero that took corporate clients from 342 to about 1,400, and lifted winter footfall by roughly 190 percent. At LaserTreat I ran operations as COO for a multi-entity clinical group.

On the population side: a doctor hotline printed on a Lifebuoy soap bar took 3,000 calls a day, a government stipend reached 10 million beneficiaries through SureCash, an ethical diagnostics model moved lab margin from about 30 to 50 percent without kickbacks, and a campus harm-reduction campaign at EMU was designed and evaluated on behavioural science.

That combination is why I founded HSREP, a two-country platform on health system resilience, and why I hold the MPH and CHES. If your problem is reach, trust or adherence at scale, that is the work.

EvidencePraava hypergrowthThe hotline on a soap barEthical diagnosticsHSREP

Are you the right fit for my company and industry?

I am the right call when there is a number that is not moving: acquisition cost, retention, reach, coverage, adherence, or an operating cost that has outrun revenue. The team needs both the diagnosis and the lever, in a US or Bangladesh context.

That is usually a company between about $1M and $50M in revenue, where a fractional growth lead a few days a month changes the outcome, or a health organisation that needs reach, trust and adherence at scale. If you are earlier than that, start with the free tools and the Growth Readiness Score. They show what to fix before you spend on anyone.

EvidenceGrowth Readiness ScoreFree tools

How do you work with clients, and what does it cost?

A few ways: operations leadership, including COO-level roles; fractional CMO or growth adviser, owning the growth number a few days a month; growth marketing consulting in Michigan and Bangladesh; brand strategy and communications; health communication and behaviour-change campaigns; digital health go-to-market; and population health strategy.

Fees are not listed because scope decides them. Every engagement starts with a free 30-minute call, and you leave it with a diagnosis either way.

EvidenceBook a free 30-minute call

What is the Impact map and how do I read it?

It is the whole career on one screen: 21 results, each with a number, traced from the insight that started it to the outcome it produced.

Pick a lens at the top, then filter by year, country or organisation. Click any result to see the evidence behind it. The Career journey tab shows the same record as a timeline, with the scope of every role.

EvidenceOpen the Impact map

Which free tool should I start with?

Start with the Growth Readiness Score: fifteen questions, about two minutes. It shows which of plan, execute or measure is weakest and hands you the tool that fixes it.

If you already know the gap: the CAC by channel calculator for acquisition cost, the LTV to CAC calculator for payback, and the coverage gap and message readability tools for health programs.

EvidenceGrowth Readiness ScoreCAC by channelLTV to CAC

How would you grow a new clinic in Dhaka, or a cash-pay clinic in the US?

I would lead with the lab, not the doctor visit. In a cash-pay market, price and trust decide everything, and a test wins on both: it is cheaper than a full consultation, concrete, and gives the patient a result they own and can act on. So design the test as the product: fast, transparent, trustworthy, and connected to a clear next step. At Praava, when COVID hit, we stood up 6-hour traveler testing and home sample collection, and that trust compounded into roughly 45% overall and about 57% B2C CAGR over multiple years. The US is arriving at the same model through at-home and direct-to-consumer diagnostics.

EvidenceThe essay: diagnostics-led care

What is HSREP?

HSREP, Health System Resilience & Economic Protection, is an independent platform I founded that publishes health-system arguments and turns them into advocacy professionals can act on. Its argument is that health protection is economic infrastructure, not a residual budget line. It grew out of an MPH capstone at Eastern Michigan University and now publishes independently, with sources, methods and limitations disclosed on every substantive piece. Season 1 was an eight-week, two-country campaign of nine published pieces that generated 57,274 gross platform-reported views and impressions at $0 ad spend. Those are impressions, not people reached. It also carries the Prevention Adoption Initiative, a proposed colorectal-screening completion pilot.

EvidenceHSREP

What have you written about vapes and nicotine pouches?

In my essay The quiet epidemic (September 2026), I argue that tobacco and the new nicotine are one epidemic wearing two faces. In the US the front line has moved to youth vaping: around 2 million middle- and high-schoolers still use a tobacco product, and about 76% of teens who vape reach for it within 30 minutes of waking. Nicotine pouches are the newest form, used by 1.7% of US middle- and high-schoolers in 2025, against 5.2% for e-cigarettes. Shame never wins this fight. The exit has to be easier than the habit: cessation support, dependence screening and youth campaigns on the platforms kids use.

EvidenceThe quiet epidemic

How do you actually run your work with AI?

I frame the problem, orchestrate the models, challenge the output, and tie the work to a number. My framework has five stages: understand the system, structure the intelligence, orchestrate the AI, challenge and verify, then implement and measure. Each step goes to the right model, a human gate sits before anything public, and logs show what happened. I design and direct AI-assisted builds; I am not a machine-learning engineer training models. I also test my site assistant in public: in the Proof Lab, its final round passed 75 of 75 answers on 23 October 2026, with every failure and fix shown.

EvidenceApplied AI

What is your Bangla page for, and who is it for?

It is my page for readers in Bangladesh, written in Bangla: growth, brand and health strategy, built in Dhaka, now based in Michigan. From Michigan I work with organizations in Bangladesh, and with Bangladeshi entrepreneurs interested in expanding into the United States. The page lists the services I offer, four cases from my work in Bangladesh, with the full case studies in English, and a short note on HSREP. It ends with an invitation to a 30-minute call: bring the number you want to change, and I will tell you plainly where I would look first and whether I am the right person.

Evidenceবাংলা পেজ